1. mTOR in Viral Hepatitis and Hepatocellular Carcinoma: Function and Treatment
    Zhuo Wang et al, 2014, BioMed Research International CrossRef
  2. Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy Combination
    Luis A. Pérez-Romasanta et al, 2021, Cancers CrossRef
  3. Sulfasalazine attenuates evading anticancer response of CD133-positive hepatocellular carcinoma cells
    Yeonhwa Song et al, 2017, Journal of Experimental & Clinical Cancer Research CrossRef
  4. Cellular and molecular effects of the mTOR inhibitor everolimus
    Uttara Saran et al, 2015, Clinical Science CrossRef
  5. Role of autophagy in regulating the radiosensitivity of tumor cells
    Yong Xin et al, 2017, Journal of Cancer Research and Clinical Oncology CrossRef
  6. mTOR inhibitor RAD001 (everolimus) induces apoptotic, not autophagic cell death, in human nasopharyngeal carcinoma cells
    YUCHEN CAI et al, 2013, International Journal of Molecular Medicine CrossRef
  7. Combination of the mTOR inhibitor RAD001 with temozolomide and radiation effectively inhibits the growth of glioblastoma cells in culture
    HÉLÈNE BURCKEL et al, 2015, Oncology Reports CrossRef
  8. Untangling knots between autophagic targets and candidate drugs, in cancer therapy
    Tao Xie et al, 2015, Cell Proliferation CrossRef
  9. RAD001-mediated STAT3 upregulation and megakaryocytic differentiation
    Yu-Chieh Su et al, 2013, Thrombosis and Haemostasis CrossRef
  10. Réirradiation de métastases ganglionnaires d’un adénocarcinome œsogastrique par une technique de tomothérapie associée à de l’évérolimus
    V. Pernin et al, 2014, Cancer/Radiothérapie CrossRef
  11. NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro
    Wen-juan Wang et al, 2013, Acta Pharmacologica Sinica CrossRef
  12. The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas
    Eric Monsalves et al, 2014, Endocrine-Related Cancer CrossRef
  13. Targeted Therapy for Hepatocellular Carcinoma
    Nitin Ohri et al, 2016, Seminars in Radiation Oncology CrossRef
  14. Synergistic killing of lung cancer cells by cisplatin and radiation via autophagy and apoptosis
    MIN LIU et al, 2014, Oncology Letters CrossRef
  15. Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches
    Mehrdad Hashemi et al, 2023, Cell Communication and Signaling CrossRef
  16. Lysosomes contribute to radioresistance in cancer
    Xin Zhang et al, 2018, Cancer Letters CrossRef
  17. Combining MTI-31 with RAD001 inhibits tumor growth and invasion of kidney cancer by activating autophagy
    Wenye Zhang et al, 2024, Journal of Applied Genetics CrossRef
  18. Low dose radiation induced senescence of human mesenchymal stromal cells and impaired the autophagy process
    Nicola Alessio et al, 2015, Oncotarget CrossRef
  19. Autophagy enhances hepatocellular carcinoma progression by activation of mitochondrial β-oxidation
    Takeo Toshima et al, 2014, Journal of Gastroenterology CrossRef
  20. Pink1/PARK2/mROS‐Dependent Mitophagy Initiates the Sensitization of Cancer Cells to Radiation
    Lei Yu et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
  21. Utilizing Carbon Ions to Treat Medulloblastomas that Exhibit Chromothripsis
    Hannah Sophia Schreiber et al, 2022, Current Stem Cell Reports CrossRef